Skip to content
10-Q

Quarterly Report

MARRONE BIO INNOVATIONS INC.

0001493152-22-013374

← back to feed
Filed
May 13, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 9, 2022 182.34M sh
Capex Q1 2022 · Mar 31, 2022 $198K
Capex Q1 2022 · Mar 31, 2021 $119K
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$8.4M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$5.02M
Long Term Debt Q1 2022 · Mar 31, 2022 $7.59M
Long Term Debt Q1 2022 · Dec 31, 2021 $7.69M
Short Term Debt Q1 2022 · Mar 31, 2022 $24.28M
Short Term Debt Q1 2022 · Dec 31, 2021 $25.91M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $9.36M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $19.62M
Stockholders Equity Q1 2022 · Mar 31, 2022 $22.87M
Stockholders Equity Q1 2022 · Dec 31, 2021 $29.65M
Stockholders Equity Q1 2022 · Mar 31, 2021 $35.35M
Stockholders Equity Q1 2022 · Dec 31, 2020 $31.41M
Current Liabilities Q1 2022 · Mar 31, 2022 $41.71M
Current Liabilities Q1 2022 · Dec 31, 2021 $45.19M
Total Liabilities Q1 2022 · Mar 31, 2022 $53.34M
Total Liabilities Q1 2022 · Dec 31, 2021 $57.4M
Current Assets Q1 2022 · Mar 31, 2022 $32.96M
Current Assets Q1 2022 · Dec 31, 2021 $42.68M
Total Assets Q1 2022 · Mar 31, 2022 $76.21M
Total Assets Q1 2022 · Dec 31, 2021 $87.06M
Eps Basic Q1 2022 · Mar 31, 2022 −$0.04
Eps Basic Q1 2022 · Mar 31, 2021 −$0.02
Sga Expense Q1 2022 · Mar 31, 2022 $10.07M
Sga Expense Q1 2022 · Mar 31, 2021 $7.48M
Rd Expense Q1 2022 · Mar 31, 2022 $2.87M
Rd Expense Q1 2022 · Mar 31, 2021 $2.3M
Net Income Q1 2022 · Mar 31, 2022 −$7.6M
Net Income Q1 2022 · Mar 31, 2021 −$3.26M
Operating Income Q1 2022 · Mar 31, 2022 −$7.02M
Operating Income Q1 2022 · Mar 31, 2021 −$3.03M
Gross Profit Q1 2022 · Mar 31, 2022 $6.21M
Gross Profit Q1 2022 · Mar 31, 2021 $6.97M
Cost Of Revenue Q1 2022 · Mar 31, 2022 $4.89M
Cost Of Revenue Q1 2022 · Mar 31, 2021 $4.07M
Revenue Q1 2022 · Mar 31, 2022 $11.1M
Revenue Q1 2022 · Mar 31, 2021 $11.04M